Company Announcements

Publication of Pricing Supplement

Source: RNS
RNS Number : 5055I
Natwest Markets PLC
02 December 2022
 

NatWest Markets Plc

Publication of Pricing Supplement

The following Pricing Supplement is available for viewing:

Pricing Supplement dated 2 December 2022 (the "Pricing Supplement") for the NatWest Markets Plc ("NatWest Markets") CHF 220,000,000 2.7825% Notes due 6 December 2027 (ISIN: CH1231312708) (the "Notes") issued under the £15,000,000,000 Euro Medium Term Note Programme of NatWest Markets (the "Programme").

The Pricing Supplement contains the final terms of the Notes and must be read in conjunction with the prospectus dated 7 December 2021 and the supplemental prospectuses dated 18 February 2022, 17 March 2022, 29 April 2022, 29 July 2022, 26 September 2022 and 28 October 2022 relating to the Programme (together, the "Prospectus"), which constitute a base prospectus for the purposes of the Prospectus Regulation (EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the European Union (Withdrawal) Act 2018, and the prospectus dated 2 December 2022 prepared by NatWest Markets in connection with admission of the Notes to trading on the SIX Swiss Exchange (the "Swiss Prospectus").

To view the Pricing Supplement, please paste the following URLs into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/5055I_1-2022-12-2.pdf

A copy of the above Pricing Supplement has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Mark Anwender

Head of Documentation and Funding

NatWest Treasury Markets

Tel: +44 7385 366760

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement (when read together with the information in the Prospectus and the Swiss Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus and the Swiss Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplement, the Prospectus and the Swiss Prospectus is not addressed. Prior to relying on the information contained in the Pricing Supplement, the Prospectus and the Swiss Prospectus, you must ascertain from the Prospectus and the Swiss Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

NatWest Markets Plc - RR3QWICWWIPCS8A4S074

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFSFFWEEESEDE